{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T08:05:57Z","timestamp":1789977957731,"version":"4.0.1"},"reference-count":251,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["232"],"award-info":[{"award-number":["232"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Seminars in Cancer Biology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/j.semcancer.2019.06.019","type":"journal-article","created":{"date-parts":[[2019,6,29]],"date-time":"2019-06-29T10:40:50Z","timestamp":1561804850000},"page":"221-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"special_numbering":"C","title":["Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications"],"prefix":"10.1016","volume":"59","author":[{"given":"Monica","family":"Marzagalli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Raimondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Montagnani Marelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta M.","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Limonta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"2014","key":"10.1016\/j.semcancer.2019.06.019_bib0005","first-page":"9","article-title":"Cancer statistics","volume":"64","author":"Siegel","year":"2014","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0010","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1016\/j.tranon.2017.09.007","article-title":"Intratumor and intertumor heterogeneity in melanoma","volume":"10","author":"Grzywa","year":"2017","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0015","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s40259-016-0208-z","article-title":"Combination treatment of patients with BRAF-mutant melanoma: a new standard of care","volume":"31","author":"Simeone","year":"2017","journal-title":"BioDrugs"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0020","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1158\/1078-0432.CCR-17-2267","article-title":"Primary and acquired resistance to immune checkpoint inhibitors in metastatic melanoma","volume":"24","author":"Gide","year":"2018","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0025","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1016\/j.ccr.2010.10.012","article-title":"Phenotypic heterogeneity among tumorigenic melanoma cells from patients that is reversible and not hierarchically organized","volume":"18","author":"Quintana","year":"2010","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0030","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.semcancer.2017.02.007","article-title":"Complexity in cancer stem cells and tumor evolution: toward precision medicine","volume":"44","author":"La Porta","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0035","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1016\/j.cell.2006.03.011","article-title":"Stem cells and cancer: two faces of eve","volume":"124","author":"Clarke","year":"2006","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0040","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s12943-016-0578-3","article-title":"Therapeutic implications of cellular and molecular biology of cancer stem cells in melanoma","volume":"16","author":"Kumar","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0045","first-page":"5821","article-title":"Identification of a cancer stem cell in human brain tumors","volume":"63","author":"Singh","year":"2003","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0050","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.1158\/0008-5472.CAN-04-3931","article-title":"Stem and progenitor-like cells contribute to the aggressive behavior of human epithelial ovarian cancer","volume":"65","author":"Bapat","year":"2005","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0055","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/sj.cdd.4402283","article-title":"Identification and expansion of the tumorigenic lung cancer stem cell population","volume":"15","author":"Eramo","year":"2008","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0060","doi-asserted-by":"crossref","first-page":"e3469","DOI":"10.1371\/journal.pone.0003469","article-title":"Detection and characterization of CD133+ cancer stem cells in human solid tumours","volume":"3","author":"Tirino","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0065","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1002\/stem.30","article-title":"Identification of gastric cancer stem cells using the cell surface marker CD44","volume":"27","author":"Takaishi","year":"2009","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc0306s24","article-title":"Culture and isolation of melanoma-initiating cells","author":"Stecca","year":"2013","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0075","doi-asserted-by":"crossref","first-page":"17","DOI":"10.4252\/wjsc.v4.i3.17","article-title":"Thoughts about cancer stem cells in solid tumors","volume":"4","author":"La Porta","year":"2012","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0080","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.canlet.2012.03.017","article-title":"Human breast and melanoma cancer stem cells biomarkers","volume":"338","author":"La Porta","year":"2013","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0085","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1038\/nrd4253","article-title":"Tackling the cancer stem cells - what challenges do they pose?","volume":"13","author":"Pattabiraman","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0090","doi-asserted-by":"crossref","first-page":"2674","DOI":"10.1002\/jcp.25796","article-title":"Cancer Stem Cells (CSCs) in melanoma: There\u2019s smoke, but is there fire?","volume":"232","author":"Brinckerhoff","year":"2017","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0095","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s12015-008-9048-7","article-title":"Cancer stem cells: lessons from melanoma","volume":"5","author":"La Porta","year":"2009","journal-title":"Stem Cell Rev."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0100","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/j.clindermatol.2012.08.014","article-title":"Melanocytes, melanocyte stem cells, and melanoma stem cells","volume":"31","author":"Lang","year":"2013","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0105","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1186\/s12885-016-2759-2","article-title":"Iterative sorting reveals CD133+ and CD133- melanoma cells as phenotypically distinct populations","volume":"16","author":"Grasso","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0110","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/embr.201338254","article-title":"Dedifferentiation and reprogramming: origins of cancer stem cells","volume":"15","author":"Friedmann-Morvinski","year":"2014","journal-title":"EMBO Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0115","doi-asserted-by":"crossref","first-page":"3098","DOI":"10.1158\/0008-5472.CAN-10-3997","article-title":"Human CD271-positive melanoma stem cells associated with metastasis establish tumor heterogeneity and long-term growth","volume":"71","author":"Civenni","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0120","doi-asserted-by":"crossref","first-page":"5272","DOI":"10.18632\/oncotarget.1967","article-title":"CD271 is an imperfect marker for melanoma initiating cells","volume":"5","author":"Cheli","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0125","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0092596","article-title":"The nerve growth factor receptor CD271 is crucial to maintain tumorigenicity and stem-like properties of melanoma cells","volume":"9","author":"Redmer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0130","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/s41598-017-19057-4","article-title":"Targeting melanoma stem cells with the Vitamin E derivative delta-tocotrienol","volume":"8","author":"Marzagalli","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0135","doi-asserted-by":"crossref","first-page":"9834","DOI":"10.1038\/s41598-017-10129-z","article-title":"CD271 determines migratory properties of melanoma cells","volume":"7","author":"Radke","year":"2017","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0140","doi-asserted-by":"crossref","first-page":"e291","DOI":"10.1038\/oncsis.2016.88","article-title":"The role of the cancer stem cell marker CD271 in DNA damage response and drug resistance of melanoma cells","volume":"6","author":"Redmer","year":"2017","journal-title":"Oncogenesis"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0145","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1038\/s41467-017-01573-6","article-title":"Low neurotrophin receptor CD271 regulates phenotype switching in melanoma","volume":"8","author":"Restivo","year":"2017","journal-title":"Nat. Commun."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0150","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12943-018-0854-5","article-title":"Deciphering mechanisms of brain metastasis in melanoma - the gist of the matter","volume":"17","author":"Redmer","year":"2018","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0155","article-title":"Immunohistochemical expression and prognostic role of CD10, CD271 and Nestin in primary and recurrent cutaneous melanoma","author":"Guanziroli","year":"2018","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0160","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.pathol.2017.12.340","article-title":"Immunohistochemical CD271 expression correlates with melanoma progress in a case-control study","volume":"50","author":"Nielsen","year":"2018","journal-title":"Pathology"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0165","doi-asserted-by":"crossref","DOI":"10.3390\/toxins8060165","article-title":"CD133, Selectively targeting the root of cancer","volume":"8","author":"Schmohl","year":"2016","journal-title":"Toxins (Basel)"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0170","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.lfs.2017.07.008","article-title":"Potential mechanisms of CD133 in cancer stem cells","volume":"184","author":"Jang","year":"2017","journal-title":"Life Sci."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0175","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.2217\/fon.15.174","article-title":"Comparative gene-expression profiling of CD133(+) and CD133(-) D10 melanoma cells","volume":"11","author":"Roudi","year":"2015","journal-title":"Future Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0180","doi-asserted-by":"crossref","first-page":"e118","DOI":"10.5301\/jbm.5000209","article-title":"Expression of CD133 cancer stem cell marker in melanoma: a systematic review and meta-analysis","volume":"31","author":"Madjd","year":"2016","journal-title":"Int. J. Biol. Markers"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0185","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18112362","article-title":"ABC Transporters in cancer stem cells: beyond chemoresistance","volume":"18","author":"Begicevic","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0190","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature06489","article-title":"Identification of cells initiating human melanomas","volume":"451","author":"Schatton","year":"2008","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0195","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.jss.2010.03.043","article-title":"Immuno-expression of human melanoma stem cell markers in tissues at different stages of the disease","volume":"163","author":"Sharma","year":"2010","journal-title":"J. Surg. Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0200","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.bbrc.2017.08.052","article-title":"ABCB5 promotes melanoma metastasis through enhancing NF-kappaB p65 protein stability","volume":"492","author":"Wang","year":"2017","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0205","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1186\/s12885-018-4583-3","article-title":"Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines","volume":"18","author":"Xiao","year":"2018","journal-title":"BMC Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0210","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.ejca.2007.01.017","article-title":"Melanoma contains CD133 and ABCG2 positive cells with enhanced tumourigenic potential","volume":"43","author":"Monzani","year":"2007","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0215","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1124\/mol.113.088609","article-title":"Molecular pharmacology of ABCG2 and its role in chemoresistance","volume":"84","author":"Stacy","year":"2013","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0220","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1038\/nmeth.3112","article-title":"Intracellular autofluorescence: a biomarker for epithelial cancer stem cells","volume":"11","author":"Miranda-Lorenzo","year":"2014","journal-title":"Nat. Methods"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0225","doi-asserted-by":"crossref","DOI":"10.2174\/1574892814666190116111827","article-title":"Tocotrienols and cancer: from the state of the art to promising novel patents","author":"Fontana","year":"2019","journal-title":"Recent Pat. Anticancer Drug Discov."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0230","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1002\/jcp.27075","article-title":"Anticancer properties of tocotrienols: a review of cellular mechanisms and molecular targets","volume":"234","author":"Montagnani Marelli","year":"2019","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0235","doi-asserted-by":"crossref","DOI":"10.1002\/9780470151808.sc0308s26","article-title":"Isolation of human melanoma stem cells using ALDH as a marker","volume":"26","author":"Luo","year":"2013","journal-title":"Curr. Protoc. Stem Cell Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0240","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.cbi.2012.10.026","article-title":"Aldehyde dehydrogenases: from eye crystallins to metabolic disease and cancer stem cells","volume":"202","author":"Vasiliou","year":"2013","journal-title":"Chem. Biol. Interact."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0245","doi-asserted-by":"crossref","first-page":"3131","DOI":"10.1002\/ijc.31609","article-title":"SOX2-mediated upregulation of CD24 promotes adaptive resistance toward targeted therapy in melanoma","volume":"143","author":"Huser","year":"2018","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0250","doi-asserted-by":"crossref","first-page":"6561","DOI":"10.1158\/0008-5472.CAN-18-0330","article-title":"CDK1 interacts with Sox2 and promotes tumor initiation in human melanoma","volume":"78","author":"Ravindran Menon","year":"2018","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0255","first-page":"967","article-title":"Reprogramming factors induce proliferation and inhibit apoptosis of melanoma cells by changing the expression of particular genes","volume":"19","author":"Wang","year":"2019","journal-title":"Mol. Med. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0260","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S1470-2045(08)70201-8","article-title":"The \"seed and soil\" hypothesis revisited","volume":"9","author":"Fidler","year":"2008","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0265","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(18)31559-9","article-title":"Melanoma","volume":"392","author":"Schadendorf","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0270","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s12943-017-0742-4","article-title":"Factors involved in cancer metastasis: a better understanding to \"seed and soil\" hypothesis","volume":"16","author":"Liu","year":"2017","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0275","doi-asserted-by":"crossref","first-page":"9245","DOI":"10.1158\/0008-5472.CAN-09-2802","article-title":"Cancer stem cells and aneuploid populations within developing tumors are the major determinants of tumor dormancy","volume":"69","author":"Kusumbe","year":"2009","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0280","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1373\/clinchem.2012.194258","article-title":"Circulating tumor cells: liquid biopsy of cancer","volume":"59","author":"Alix-Panabieres","year":"2013","journal-title":"Clin. Chem."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0285","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1007\/s00262-012-1387-1","article-title":"Circulating tumor cells as therapy-related biomarkers in cancer patients, Cancer immunol","volume":"62","author":"Gorges","year":"2013","journal-title":"Immunother."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0290","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.semcancer.2017.02.011","article-title":"Cancer stem cells: the root of tumor recurrence and metastases","volume":"44","author":"Peitzsch","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0295","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1038\/nbt.2576","article-title":"Identification of a population of blood circulating tumor cells from breast cancer patients that initiates metastasis in a xenograft assay","volume":"31","author":"Baccelli","year":"2013","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0300","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8629234","article-title":"Prostate cancer stem cell markers drive progression, therapeutic resistance, and bone metastasis","volume":"2017","author":"Harris","year":"2017","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0305","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12929-018-0426-4","article-title":"Cancer stem cells as key drivers of tumour progression","volume":"25","author":"Ayob","year":"2018","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0310","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/1479-5876-10-192","article-title":"Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells","volume":"10","author":"Freeman","year":"2012","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0315","first-page":"8947","article-title":"Increased expression of melanoma stem cell marker CD271 in metastatic melanoma to the brain","volume":"7","author":"Guo","year":"2014","journal-title":"Int. J. Clin. Exp. Pathol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0320","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1016\/j.celrep.2016.07.004","article-title":"Antibody therapy targeting CD47 and CD271 effectively suppresses melanoma metastasis in patient-derived xenografts","volume":"16","author":"Ngo","year":"2016","journal-title":"Cell Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0325","doi-asserted-by":"crossref","first-page":"15030","DOI":"10.1038\/celldisc.2015.30","article-title":"Increased CD271 expression by the NF-kB pathway promotes melanoma cell survival and drives acquired resistance to BRAF inhibitor vemurafenib","volume":"1","author":"Lehraiki","year":"2015","journal-title":"Cell Discov."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0330","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.canlet.2015.02.041","article-title":"Vemurafenib resistance selects for highly malignant brain and lung-metastasizing melanoma cells","volume":"361","author":"Zubrilov","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0335","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/CMR.0000000000000144","article-title":"Targeting ALDH1 to decrease tumorigenicity, growth and metastasis of human melanoma","volume":"25","author":"Yue","year":"2015","journal-title":"Melanoma Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0340","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1038\/jid.2015.127","article-title":"Circulating melanoma cell subpopulations: their heterogeneity and differential responses to treatment","volume":"135","author":"Gray","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0345","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/nrc822","article-title":"Epithelial-mesenchymal transitions in tumour progression","volume":"2","author":"Thiery","year":"2002","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0350","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc.2017.118","article-title":"EMT in cancer","volume":"18","author":"Brabletz","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0355","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1016\/j.cell.2008.03.027","article-title":"The epithelial-mesenchymal transition generates cells with properties of stem cells","volume":"133","author":"Mani","year":"2008","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0360","doi-asserted-by":"crossref","first-page":"e2888","DOI":"10.1371\/journal.pone.0002888","article-title":"Generation of breast cancer stem cells through epithelial-mesenchymal transition","volume":"3","author":"Morel","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0365","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.semcancer.2012.04.001","article-title":"Cancer stem cells and epithelial-mesenchymal transition: concepts and molecular links","volume":"22","author":"Scheel","year":"2012","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0370","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ccr.2013.08.018","article-title":"A switch in the expression of embryonic EMT-inducers drives the development of malignant melanoma","volume":"24","author":"Caramel","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0375","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.canlet.2017.01.029","article-title":"Potential therapeutic targets of epithelial-mesenchymal transition in melanoma","volume":"391","author":"Pearlman","year":"2017","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0380","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1038\/jid.2011.142","article-title":"Transcriptional activation of ZEB1 by Slug leads to cooperative regulation of the epithelial-mesenchymal transition-like phenotype in melanoma","volume":"131","author":"Wels","year":"2011","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0385","first-page":"552","article-title":"Altered expression and splicing of ESRP1 in malignant melanoma correlates with epithelial-mesenchymal status and tumor-associated immune cytolytic activity, Cancer immunol","volume":"4","author":"Yao","year":"2016","journal-title":"Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0390","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1111\/pcmr.12149","article-title":"GLI2 cooperates with ZEB1 for transcriptional repression of CDH1 expression in human melanoma cells","volume":"26","author":"Perrot","year":"2013","journal-title":"Pigment Cell Melanoma Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0395","doi-asserted-by":"crossref","first-page":"325","DOI":"10.5582\/bst.2015.01106","article-title":"Decrease of ZEB1 expression inhibits the B16F10 cancer stem-like properties","volume":"9","author":"Zhao","year":"2015","journal-title":"Biosci. Trends"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0400","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1038\/cdd.2014.44","article-title":"Identification of a ZEB2-MITF-ZEB1 transcriptional network that controls melanogenesis and melanoma progression","volume":"21","author":"Denecker","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0405","doi-asserted-by":"crossref","first-page":"82511","DOI":"10.18632\/oncotarget.12733","article-title":"IGF-1 contributes to the expansion of melanoma-initiating cells through an epithelial-mesenchymal transition process","volume":"7","author":"Le Coz","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0410","doi-asserted-by":"crossref","first-page":"20636","DOI":"10.18632\/oncotarget.4114","article-title":"Insulin-like growth factor binding protein 5 (IGFBP5) functions as a tumor suppressor in human melanoma cells","volume":"6","author":"Wang","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0415","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/1478-811X-12-24","article-title":"Mesenchymal to amoeboid transition is associated with stem-like features of melanoma cells","volume":"12","author":"Taddei","year":"2014","journal-title":"Cell Commun. Signal"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0420","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1056\/NEJMra0706596","article-title":"Tumor angiogenesis","volume":"358","author":"Kerbel","year":"2008","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0425","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/jclinpath-2015-203482","article-title":"Angiogenesis in melanoma: an update with a focus on current targeted therapies","volume":"69","author":"Jour","year":"2016","journal-title":"J. Clin. Pathol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0430","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1701350","article-title":"Melanoma topology reveals a stem-like phenotype that promotes angiogenesis","volume":"3","author":"Lee","year":"2017","journal-title":"Sci. Adv."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0435","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1016\/j.jid.2016.07.024","article-title":"Notch1-MAPK signaling axis regulates CD133(+) cancer stem cell-mediated melanoma growth and angiogenesis","volume":"136","author":"Kumar","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0440","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nrc1092","article-title":"Vasculogenic mimicry and tumour-cell plasticity: lessons from melanoma","volume":"3","author":"Hendrix","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0445","first-page":"309","article-title":"Vasculogenic mimicry: lessons from melanocytic tumors","volume":"29","author":"Spiliopoulos","year":"2015","journal-title":"In Vivo (Brooklyn)"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0450","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.pharmthera.2016.01.006","article-title":"Tumor cell vascular mimicry: novel targeting opportunity in melanoma","volume":"159","author":"Hendrix","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0455","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1158\/0008-5472.CAN-10-1660","article-title":"VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth","volume":"71","author":"Frank","year":"2011","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0460","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1097\/CMR.0b013e328343a237","article-title":"VEGFR1 and PKCalpha signaling control melanoma vasculogenic mimicry in a VEGFR2 kinase-independent manner","volume":"21","author":"Vartanian","year":"2011","journal-title":"Melanoma Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0465","first-page":"588","article-title":"Stem cell marker CD271 is expressed by vasculogenic mimicry-forming uveal melanoma cells in three-dimensional cultures","volume":"18","author":"Valyi-Nagy","year":"2012","journal-title":"Mol. Vis."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0470","doi-asserted-by":"crossref","first-page":"37426","DOI":"10.18632\/oncotarget.6055","article-title":"Targeting Syndecan-1, a molecule implicated in the process of vasculogenic mimicry, enhances the therapeutic efficacy of the L19-IL2 immunocytokine in human melanoma xenografts","volume":"6","author":"Orecchia","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0475","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/CMR.0000000000000308","article-title":"Inhibitor of vasculogenic mimicry restores sensitivity of resistant melanoma cells to DNA-damaging agents","volume":"27","author":"Vartanian","year":"2017","journal-title":"Melanoma Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0480","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.mvr.2015.12.001","article-title":"Putative CD133+ melanoma cancer stem cells induce initial angiogenesis in vivo","volume":"104","author":"Zimmerer","year":"2016","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0485","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.mvr.2018.10.008","article-title":"Reversing effect of Lupeol on vasculogenic mimicry in murine melanoma progression","volume":"121","author":"Bhattacharyya","year":"2019","journal-title":"Microvasc. Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0490","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12307-014-0156-4","article-title":"Angiotropism, pericytic mimicry and extravascular migratory metastasis in melanoma: an alternative to intravascular cancer dissemination","volume":"7","author":"Lugassy","year":"2014","journal-title":"Cancer Microenviron."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0495","doi-asserted-by":"crossref","first-page":"23834","DOI":"10.1038\/srep23834","article-title":"Imaging of angiotropism\/vascular co-option in a murine model of brain melanoma: implications for melanoma progression along extravascular pPathways","volume":"6","author":"Bentolila","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0500","doi-asserted-by":"crossref","first-page":"7175","DOI":"10.18632\/oncotarget.12739","article-title":"The concept of immune surveillance against tumors","volume":"8","author":"Ribatti","year":"2017","journal-title":"The first theories, Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0505","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/S0140-6736(07)61050-2","article-title":"Incidence of cancers in people with HIV\/AIDS compared with immunosuppressed transplant recipients: a meta-analysis","volume":"370","author":"Grulich","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0510","doi-asserted-by":"crossref","first-page":"360","DOI":"10.3389\/fimmu.2014.00360","article-title":"Cancer stem cell immunology: key to understanding tumorigenesis and tumor immune escape?","volume":"5","author":"Bruttel","year":"2014","journal-title":"Front. Immunol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0515","doi-asserted-by":"crossref","first-page":"106132","DOI":"10.18632\/oncotarget.22190","article-title":"Immune system and melanoma biology: a balance between immunosurveillance and immune escape","volume":"8","author":"Passarelli","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0520","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.ejca.2013.11.014","article-title":"Immunology of cancer stem cells in solid tumours","volume":"50","author":"Maccalli","year":"2014","journal-title":"A review, Eur. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0525","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1749-6632.2009.04568.x","article-title":"Antitumor immunity and cancer stem cells","volume":"1176","author":"Schatton","year":"2009","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0530","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1158\/0008-5472.CAN-09-1592","article-title":"Modulation of T-cell activation by malignant melanoma initiating cells","volume":"70","author":"Schatton","year":"2010","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0535","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nature09161","article-title":"Human melanoma-initiating cells express neural crest nerve growth factor receptor CD271","volume":"466","author":"Boiko","year":"2010","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0540","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1038\/jid.2013.490","article-title":"CD271 on melanoma cell is an IFN-gamma-inducible immunosuppressive factor that mediates downregulation of melanoma antigens","volume":"134","author":"Furuta","year":"2014","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0545","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1007\/s00262-009-0672-0","article-title":"Cancer\/testis antigens can be immunological targets in clonogenic CD133+ melanoma cells, Cancer immunol","volume":"58","author":"Gedye","year":"2009","journal-title":"Immunother."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0550","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.intimp.2017.09.019","article-title":"Effective tumor immunity to melanoma mediated by B16F10 cancer stem cell vaccine","volume":"52","author":"Zhao","year":"2017","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0555","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1186\/s13046-018-0929-6","article-title":"Apigenin suppresses PD-L1 expression in melanoma and host dendritic cells to elicit synergistic therapeutic effects","volume":"37","author":"Xu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0560","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1097\/00002371-200405000-00002","article-title":"Identification of multiple antigens recognized by tumor-infiltrating lymphocytes from a single patient: tumor escape by antigen loss and loss of MHC expression","volume":"27","author":"Khong","year":"2004","journal-title":"J. Immunother."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0565","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/nm730","article-title":"Tumor-associated B7-H1 promotes T-cell apoptosis: a potential mechanism of immune evasion","volume":"8","author":"Dong","year":"2002","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0570","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1002\/bies.200900058","article-title":"Identification and targeting of cancer stem cells","volume":"31","author":"Schatton","year":"2009","journal-title":"Bioessays"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0575","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.semcancer.2018.05.001","article-title":"Cancer stem cells: regulation programs, immunological properties and immunotherapy","volume":"52","author":"Zhang","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0580","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2017.1408750","article-title":"Melanoma induced immunosuppression is mediated by hematopoietic dysregulation","volume":"7","author":"Kamran","year":"2018","journal-title":"Oncoimmunology"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0585","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrc3498","article-title":"Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?","volume":"13","author":"Holzel","year":"2013","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0590","first-page":"679","article-title":"Interplay between inflammatory tumor microenvironment and cancer stem cells","volume":"16","author":"Zhang","year":"2018","journal-title":"Oncol. Lett."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0595","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.stem.2018.12.009","article-title":"Cancer Stem Cells: The architects of the tumor eEcosystem","volume":"24","author":"Prager","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0600","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0605","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.ccr.2012.02.014","article-title":"Metabolic reprogramming: a cancer hallmark even warburg did not anticipate","volume":"21","author":"Ward","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0610","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1038\/ncb3124","article-title":"Metabolic pathways promoting cancer cell survival and growth","volume":"17","author":"Boroughs","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0615","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1126\/science.123.3191.309","article-title":"On the origin of cancer cells","volume":"123","author":"Warburg","year":"1956","journal-title":"Science"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0620","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2007.10.002","article-title":"The biology of cancer: metabolic reprogramming fuels cell growth and proliferation","volume":"7","author":"DeBerardinis","year":"2008","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0625","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/nrclinonc.2017.1","article-title":"Cancer metabolism: a therapeutic perspective","volume":"14","author":"Martinez-Outschoorn","year":"2017","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0630","doi-asserted-by":"crossref","first-page":"42626","DOI":"10.1074\/jbc.M111.282046","article-title":"Comparative metabolic flux profiling of melanoma cell lines: beyond the Warburg effect","volume":"286","author":"Scott","year":"2011","journal-title":"J. Biol.Chem."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0635","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1038\/onc.2016.198","article-title":"Metabolic rewiring in melanoma","volume":"36","author":"Ratnikov","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0640","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.18632\/oncotarget.1420","article-title":"Mitochondrial oxidative stress is the Achille\u2019s heel of melanoma cells resistant to Braf-mutant inhibitor","volume":"4","author":"Corazao-Rozas","year":"2013","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0645","first-page":"164","article-title":"Molecular drivers of cellular metabolic reprogramming in melanoma, Trends Mol","volume":"21","author":"Abildgaard","year":"2015","journal-title":"Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0650","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.phrs.2016.02.009","article-title":"Targeting metabolic reprogramming as a potential therapeutic strategy in melanoma","volume":"107","author":"Smith","year":"2016","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0655","doi-asserted-by":"crossref","first-page":"14190","DOI":"10.1038\/s41598-018-31170-6","article-title":"Mitochondrial transcription factor A (TFAM) shapes metabolic and invasion gene signatures in melanoma","volume":"8","author":"Araujo","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0660","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1186\/s13058-016-0712-6","article-title":"Cancer stem cell metabolism","volume":"18","author":"Peiris-Pages","year":"2016","journal-title":"Breast Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0665","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/bjc.2016.152","article-title":"Hallmarks of cancer stem cell metabolism","volume":"114","author":"Sancho","year":"2016","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0670","doi-asserted-by":"crossref","first-page":"32843","DOI":"10.1074\/jbc.M111.260935","article-title":"Metabolic alterations in highly tumorigenic glioblastoma cells: preference for hypoxia and high dependency on glycolysis","volume":"286","author":"Zhou","year":"2011","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0675","doi-asserted-by":"crossref","first-page":"86","DOI":"10.4161\/15384101.2014.974419","article-title":"Metabolic reprogramming orchestrates cancer stem cell properties in nasopharyngeal carcinoma","volume":"14","author":"Shen","year":"2015","journal-title":"Cell Cycle"},{"issue":"5","key":"10.1016\/j.semcancer.2019.06.019_bib0680","doi-asserted-by":"crossref","first-page":"5735","DOI":"10.1007\/s13277-016-4945-x","article-title":"Cancer stem cells, metabolism, and therapeutic significance","volume":"37","author":"Yang","year":"2016","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0685","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.semcancer.2017.06.012","article-title":"Mitochondrial biology in cancer stem cells","volume":"47","author":"Loureiro","year":"2017","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0690","doi-asserted-by":"crossref","first-page":"319","DOI":"10.5483\/BMBRep.2018.51.7.112","article-title":"Cancer stem cell metabolism: target for cancer therapy","volume":"51","author":"Chae","year":"2018","journal-title":"BMB Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0695","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1042\/BCJ20170164","article-title":"Cancer stem cells (CSCs): metabolic strategies for their identification and eradication","volume":"475","author":"De Francesco","year":"2018","journal-title":"Biochem. J."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0700","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/1027453","article-title":"Oncogenic metabolism acts as a prerequisite step for induction of cancer metastasis and cancer stem cell pPhenotype","volume":"2018","author":"Lee","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0705","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1080\/15384101.2018.1515551","article-title":"A mitochondrial based oncology platform for targeting cancer stem cells (CSCs): MITO-ONC-RX","volume":"17","author":"Sotgia","year":"2018","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0710","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1038\/s41388-018-0141-3","article-title":"Metabolic features of cancer stem cells: the emerging role of lipid metabolism","volume":"37","author":"Mancini","year":"2018","journal-title":"Oncogene"},{"issue":"8","key":"10.1016\/j.semcancer.2019.06.019_bib0715","doi-asserted-by":"crossref","DOI":"10.1242\/dmm.033464","article-title":"Metabolic traits of cancer stem cells","volume":"11","author":"Peixoto","year":"2018","journal-title":"Dis. Model. Mech."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0720","doi-asserted-by":"crossref","first-page":"e189","DOI":"10.1038\/oncsis.2015.49","article-title":"Lipid metabolic reprogramming in cancer cells","volume":"5","author":"Beloribi-Djefaflia","year":"2016","journal-title":"Oncogenesis"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0725","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147717","article-title":"Inhibition of fatty acid synthase decreases expression of sStemness markers in glioma stem cells","volume":"11","author":"Yasumoto","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0730","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.cmet.2015.12.004","article-title":"NANOG metabolically reprograms tumor-iInitiating stem-like cells through tumorigenic changes in oxidative phosphorylation and fatty acid metabolism","volume":"23","author":"Chen","year":"2016","journal-title":"Cell Metab."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0735","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.stem.2016.06.001","article-title":"Leukemic stem cells evade chemotherapy by metabolic adaptation to an adipose tissue niche","volume":"19","author":"Ye","year":"2016","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0740","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature20791","article-title":"Targeting metastasis-initiating cells through the fatty acid receptor CD36","volume":"541","author":"Pascual","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0745","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/1656053","article-title":"An overview of lipid droplets in cancer and cancer stem cells","volume":"2017","author":"Tirinato","year":"2017","journal-title":"Stem Cells Int."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0750","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.trecan.2017.01.005","article-title":"Glutamine metabolism in cancer: understanding the heterogeneity","volume":"3","author":"Cluntun","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0755","doi-asserted-by":"crossref","first-page":"31151","DOI":"10.18632\/oncotarget.5150","article-title":"Inhibition of glutamine metabolism counteracts pancreatic cancer stem cell features and sensitizes cells to radiotherapy","volume":"6","author":"Li","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0760","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1038\/s41598-017-18762-4","article-title":"Effects of metformin on colorectal cancer stem cells depend on alterations in glutamine metabolism","volume":"8","author":"Kim","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0765","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/ncb3272","article-title":"Glutamine synthetase activity fuels nucleotide biosynthesis and supports growth of glutamine-restricted glioblastoma","volume":"17","author":"Tardito","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0770","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.ebiom.2018.11.063","article-title":"Targeting glutaminase 1 attenuates stemness properties in hepatocellular carcinoma by increasing reactive oxygen species and suppressing Wnt\/beta-catenin pathway","volume":"39","author":"Li","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0775","doi-asserted-by":"crossref","first-page":"30502","DOI":"10.1038\/srep30502","article-title":"Vitamin E delta-tocotrienol triggers endoplasmic reticulum stress-mediated apoptosis in human melanoma cells","volume":"6","author":"Montagnani Marelli","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0780","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ccr.2012.11.020","article-title":"PGC1alpha expression defines a subset of human melanoma tumors with increased mitochondrial capacity and resistance to oxidative stress","volume":"23","author":"Vazquez","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0785","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.ccr.2013.02.003","article-title":"Oncogenic BRAF regulates oxidative metabolism via PGC1alpha and MITF","volume":"23","author":"Haq","year":"2013","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0790","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.bbagen.2018.01.018","article-title":"Melanoma metabolism contributes to the cellular responses to MAPK\/ERK pathway inhibitors","volume":"1862","author":"Marchetti","year":"2018","journal-title":"Biochim. Biophys. Acta Gen. Subj."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0795","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.molcel.2015.01.003","article-title":"Mitochondrial division is requisite to RAS-induced transformation and targeted by oncogenic MAPK pathway inhibitors","volume":"57","author":"Serasinghe","year":"2015","journal-title":"Mol. Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0800","doi-asserted-by":"crossref","first-page":"39473","DOI":"10.18632\/oncotarget.7790","article-title":"Mitochondrial oxidative phosphorylation controls cancer cell\u2019s life and death decisions upon exposure to MAPK inhibitors","volume":"7","author":"Corazao-Rozas","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0805","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161803","article-title":"Expression of cCell-surface marker ABCB5 causes characteristic modifications of glucose, amino acid and phospholipid metabolism in the G3361 melanoma-initiating cell line","volume":"11","author":"Lutz","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0810","doi-asserted-by":"crossref","first-page":"3609","DOI":"10.1038\/onc.2016.520","article-title":"Downregulation of PCK2 remodels tricarboxylic acid cycle in tumor-repopulating cells of melanoma","volume":"36","author":"Luo","year":"2017","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0815","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1158\/0008-5472.CAN-14-2615","article-title":"Upregulation of cytosolic phosphoenolpyruvate carboxykinase is a critical metabolic event in melanoma cells that repopulate tumors","volume":"75","author":"Li","year":"2015","journal-title":"Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0820","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6816508","article-title":"beta3-Adrenoreceptors control mitochondrial dormancy in melanoma and embryonic stem cells","volume":"2018","author":"Calvani","year":"2018","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0825","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1002\/stem.1953","article-title":"Letter to the editor: an intriguing relationship between lipid droplets, cholesterol-binding protein CD133 and Wnt\/beta-catenin signaling pathway in carcinogenesis","volume":"33","author":"Rappa","year":"2015","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0830","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1016\/j.yexcr.2013.01.003","article-title":"Wnt interaction and extracellular release of prominin-1\/CD133 in human malignant melanoma cells","volume":"319","author":"Rappa","year":"2013","journal-title":"Exp. Cell Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0835","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18061271","article-title":"Lipid storage and autophagy in melanoma cancer cells","volume":"18","author":"Giampietri","year":"2017","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0840","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1186\/s13046-018-0989-7","article-title":"Inhibition of Stearoyl-CoA desaturase 1 reverts BRAF and MEK inhibition-induced selection of cancer stem cells in BRAF-mutated melanoma","volume":"37","author":"Pisanu","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0845","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4161\/cc.27031","article-title":"Hypoxia-resistant profile implies vulnerability of cancer stem cells to physiological agents, which suggests new therapeutic targets","volume":"13","author":"Cipolleschi","year":"2014","journal-title":"Cell Cycle"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0850","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.molonc.2015.08.003","article-title":"Resistance to BRAF inhibitors induces glutamine dependency in melanoma cells","volume":"10","author":"Baenke","year":"2016","journal-title":"Mol. Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0855","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.cca.2018.04.033","article-title":"Signalling mechanism(s) of epithelial-mesenchymal transition and cancer stem cells in tumour therapeutic resistance","volume":"483","author":"Cai","year":"2018","journal-title":"Clin. Chim. Acta"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0860","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/nature03319","article-title":"Wnt signalling in stem cells and cancer","volume":"434","author":"Reya","year":"2005","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0865","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrclinonc.2015.61","article-title":"Hedgehog, and Wnt pathways in cancer stem cells: clinical update","volume":"12","author":"Takebe","year":"2015","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0870","doi-asserted-by":"crossref","first-page":"5","DOI":"10.21037\/sci.2018.02.02","article-title":"Targeting Notch signalling pathway of cancer stem cells","volume":"5","author":"Venkatesh","year":"2018","journal-title":"Stem Cell Investig."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0875","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000084505","article-title":"Transforming growth factor-beta signaling during epithelial-mesenchymal transformation: implications for embryogenesis and tumor metastasis","volume":"179","author":"Nawshad","year":"2005","journal-title":"Cells Tissues Organs (Print)"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0880","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1038\/nrc1926","article-title":"Tumour microenvironment: TGFbeta: the molecular Jekyll and Hyde of cancer","volume":"6","author":"Bierie","year":"2006","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0885","doi-asserted-by":"crossref","first-page":"5764","DOI":"10.1038\/sj.onc.1208927","article-title":"TGF-beta and epithelial-to-mesenchymal transitions","volume":"24","author":"Zavadil","year":"2005","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0890","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.trecan.2016.11.008","article-title":"Targeting TGF-beta signaling in cancer","volume":"3","author":"Colak","year":"2017","journal-title":"Trends Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0895","article-title":"Transforming growth factor-beta signaling: tumorigenesis and targeting for cancer therapy","author":"Ahmadi","year":"2018","journal-title":"J. Cell. Physiol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0900","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ceb.2017.10.001","article-title":"Mechanistic insight into contextual TGF-beta signaling","volume":"51","author":"Zhang","year":"2018","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0905","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/ng1001-117","article-title":"TGF-beta signaling in tumor suppression and cancer progression","volume":"29","author":"Derynck","year":"2001","journal-title":"Nat. Genet."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0910","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/nrc1208","article-title":"Cytostatic and apoptotic actions of TGF-beta in homeostasis and cancer","volume":"3","author":"Siegel","year":"2003","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0915","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cell.2013.06.005","article-title":"Poised chromatin at the ZEB1 promoter enables breast cancer cell plasticity and enhances tumorigenicity","volume":"154","author":"Chaffer","year":"2013","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0920","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/CMR.0000000000000325","article-title":"Mesenchymal stem cells induce epithelial mesenchymal transition in melanoma by paracrine secretion of transforming growth factor-beta","volume":"27","author":"Lv","year":"2017","journal-title":"Melanoma Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0925","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/exd.12580","article-title":"PI3K signalling is required for a TGFbeta-induced epithelial-mesenchymal-like transition (EMT-like) in human melanoma cells","volume":"24","author":"Schlegel","year":"2015","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0930","doi-asserted-by":"crossref","first-page":"2899","DOI":"10.1016\/j.cub.2015.09.054","article-title":"TGF-beta-Induced transcription sustains amoeboid melanoma migration and dissemination","volume":"25","author":"Cantelli","year":"2015","journal-title":"Curr. Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0935","doi-asserted-by":"crossref","first-page":"12027","DOI":"10.18632\/oncotarget.2482","article-title":"Melanoma-initiating cells exploit M2 macrophage TGFbeta and arginase pathway for survival and proliferation","volume":"5","author":"Tham","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0940","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/labinvest.2016.107","article-title":"Targeting melanoma with front-line therapy does not abrogate Nodal-expressing tumor cells","volume":"97","author":"Hendrix","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0945","doi-asserted-by":"crossref","first-page":"E242","DOI":"10.1002\/ijc.29198","article-title":"Divergence(s) in nodal signaling between aggressive melanoma and embryonic stem cells","volume":"136","author":"Khalkhali-Ellis","year":"2015","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0950","doi-asserted-by":"crossref","first-page":"630","DOI":"10.4161\/cbt.2.6.678","article-title":"Mechanisms by which IGF-I may promote cancer","volume":"2","author":"Grimberg","year":"2003","journal-title":"Cancer Biol. Ther."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0955","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1007\/978-1-4614-0899-4_14","article-title":"Notch signaling pathway and cancer metastasis","volume":"727","author":"Hu","year":"2012","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0960","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.7150\/jca.18955","article-title":"Correlation of ALDH1 and Notch3 expression: clinical implication in ovarian carcinomas","volume":"8","author":"Kim","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib0965","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s10238-014-0300-y","article-title":"Activated Notch1 expression is associated with angiogenesis in cutaneous melanoma","volume":"15","author":"Murtas","year":"2015","journal-title":"Clin. Exp. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0970","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1038\/labinvest.2017.1","article-title":"Notch3 signaling-mediated melanoma-endothelial crosstalk regulates melanoma stem-like cell homeostasis and niche morphogenesis","volume":"97","author":"Hsu","year":"2017","journal-title":"Lab. Invest."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0975","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1111\/cas.12978","article-title":"Notch4+ cancer stem-like cells promote the metastatic and invasive ability of melanoma","volume":"107","author":"Lin","year":"2016","journal-title":"Cancer Sci."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0980","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.gendis.2015.12.004","article-title":"Wnt\/beta-catenin signaling plays an ever-expanding role in stem cell self-renewal, tumorigenesis and cancer chemoresistance","volume":"3","author":"Mohammed","year":"2016","journal-title":"Genes Dis."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0985","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.3892\/ijo.2017.4129","article-title":"Canonical and non-canonical WNT signaling in cancer stem cells and their niches: cellular heterogeneity, omics reprogramming, targeted therapy and tumor plasticity (Review)","volume":"51","author":"Katoh","year":"2017","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0990","first-page":"419","article-title":"The Role of canonical Wnt signaling in regulating radioresistance, Cell Physiol","volume":"48","author":"Zhao","year":"2018","journal-title":"Biochem."},{"key":"10.1016\/j.semcancer.2019.06.019_bib0995","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/j.cell.2012.05.012","article-title":"Wnt\/beta-catenin signaling and disease","volume":"149","author":"Clevers","year":"2012","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1000","first-page":"23","article-title":"The role of tumor microenvironment in development and progression of malignant melanomas - a systematic review","volume":"59","author":"Gurzu","year":"2018","journal-title":"Rom. J. Morphol. Embryol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1005","first-page":"2973","article-title":"Links between cancer stem cells and epithelial-mesenchymal transition","volume":"8","author":"Wang","year":"2015","journal-title":"Onco. Ther."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1010","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2174\/156652409789105570","article-title":"Hedgehog target genes: mechanisms of carcinogenesis induced by aberrant hedgehog signaling activation","volume":"9","author":"Katoh","year":"2009","journal-title":"Curr. Mol. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1015","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1002\/stem.1160","article-title":"Hedgehog-GLI signaling drives self-renewal and tumorigenicity of human melanoma-initiating cells","volume":"30","author":"Santini","year":"2012","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1020","doi-asserted-by":"crossref","first-page":"4697","DOI":"10.1038\/onc.2014.71","article-title":"SOX2 regulates self-renewal and tumorigenicity of human melanoma-initiating cells","volume":"33","author":"Santini","year":"2014","journal-title":"Oncogene"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1025","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1749-8546-6-31","article-title":"Potential applications of curcumin and its novel synthetic analogs and nanotechnology-based formulations in cancer prevention and therapy","volume":"6","author":"Mimeault","year":"2011","journal-title":"Chin. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1030","doi-asserted-by":"crossref","first-page":"716","DOI":"10.3109\/07388551.2015.1015957","article-title":"Molecular mechanisms of drug resistance and its reversal in cancer","volume":"36","author":"Kartal-Yandim","year":"2016","journal-title":"Crit. Rev. Biotechnol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1035","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1111\/1440-1681.12581","article-title":"Molecular mechanisms for tumour resistance to chemotherapy","volume":"43","author":"Pan","year":"2016","journal-title":"Clin. Exp. Pharmac.l Physiol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1040","doi-asserted-by":"crossref","first-page":"E4726","DOI":"10.1073\/pnas.1404656111","article-title":"Single-cell analyses of transcriptional heterogeneity during drug tolerance transition in cancer cells by RNA sequencing","volume":"111","author":"Lee","year":"2014","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1045","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.cell.2018.03.041","article-title":"Chemoresistance evolution in triple-negative breast cancer delineated by single-cell sequencing","volume":"173","author":"Kim","year":"2018","journal-title":"Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1050","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1038\/s41568-018-0056-x","article-title":"Stem cell fate in cancer growth, progression and therapy resistance","volume":"18","author":"Lytle","year":"2018","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1055","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.semcancer.2018.11.006","article-title":"Therapy resistance mediated by cancer stem cells","volume":"53","author":"Steinbichler","year":"2018","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1060","doi-asserted-by":"crossref","first-page":"183","DOI":"10.4252\/wjsc.v10.i12.183","article-title":"Cancer stem cell impact on clinical oncology","volume":"10","author":"Toledo-Guzman","year":"2018","journal-title":"World J. Stem Cells"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1065","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.stem.2018.11.011","article-title":"Phenotypic plasticity: driver of cancer initiation, progression, and therapy resistance","volume":"24","author":"Gupta","year":"2019","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1070","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1038\/nm0901-1028","article-title":"The ABC transporter Bcrp1\/ABCG2 is expressed in a wide variety of stem cells and is a molecular determinant of the side-population phenotype","volume":"7","author":"Zhou","year":"2001","journal-title":"Nat. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1075","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/2001-1326-2-3","article-title":"Mechanisms of chemoresistance in cancer stem cells","volume":"2","author":"Abdullah","year":"2013","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1080","doi-asserted-by":"crossref","first-page":"9879","DOI":"10.1007\/s13277-014-2277-2","article-title":"Reversing paclitaxel resistance in ovarian cancer cells via inhibition of the ABCB1 expressing side population","volume":"35","author":"Eyre","year":"2014","journal-title":"Tumour Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1085","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1081\/DMR-120034001","article-title":"Role of human aldehyde dehydrogenases in endobiotic and xenobiotic metabolism","volume":"36","author":"Vasiliou","year":"2004","journal-title":"Drug Metab. Rev."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1090","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.pharmthera.2016.02.008","article-title":"Cancer stem cells and chemoresistance: the smartest survives the raid","volume":"160","author":"Zhao","year":"2016","journal-title":"Pharmacol. Ther."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1095","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1158\/1078-0432.CCR-09-2846","article-title":"Targeting Hedgehog--a cancer stem cell pathway","volume":"16","author":"Merchant","year":"2010","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1100","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.ccr.2012.07.016","article-title":"Suppression of acquired docetaxel resistance in prostate cancer through depletion of notch- and hedgehog-dependent tumor-initiating cells","volume":"22","author":"Domingo-Domenech","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1105","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1038\/nature05236","article-title":"Glioma stem cells promote radioresistance by preferential activation of the DNA damage response","volume":"444","author":"Bao","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1110","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.semcancer.2015.09.009","article-title":"Radiation resistance: cancer stem cells (CSCs) and their enigmatic pro-survival signaling","volume":"35","author":"Skvortsova","year":"2015","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1115","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.3892\/or.2017.5963","article-title":"Phenotype characterization of human melanoma cells resistant to dabrafenib","volume":"38","author":"Cordaro","year":"2017","journal-title":"Oncol. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1120","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.canlet.2013.09.024","article-title":"Identification and analysis of CD133(+) melanoma stem-like cells conferring resistance to taxol: an insight into the mechanisms of their resistance and response","volume":"343","author":"El-Khattouti","year":"2014","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1125","doi-asserted-by":"crossref","first-page":"14940","DOI":"10.18632\/oncotarget.7496","article-title":"Salmonella VNP20009-mediated RNA interference of ABCB5 moderated chemoresistance of melanoma stem cell and suppressed tumor growth more potently","volume":"7","author":"Zhang","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1130","first-page":"615","article-title":"Blockade of integrin beta3 signals to reverse the stem-like phenotype and drug resistance in melanoma, Cancer chemothe","volume":"83","author":"Zhu","year":"2019","journal-title":"Pharmacol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1135","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1073\/pnas.1009069108","article-title":"Eradication of melanomas by targeted elimination of a minor subset of tumor cells","volume":"108","author":"Schmidt","year":"2011","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1140","doi-asserted-by":"crossref","first-page":"22","DOI":"10.18632\/oncotarget.437","article-title":"Regression of metastatic melanoma in a patient by antibody targeting of cancer stem cells","volume":"3","author":"Schlaak","year":"2012","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1145","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1166\/jbn.2015.2129","article-title":"CD20 Antibody-conjugated immunoliposomes for targeted chemotherapy of melanoma cancer initiating cells","volume":"11","author":"Song","year":"2015","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1150","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/aps.2017.166","article-title":"Salinomycin-loaded lipid-polymer nanoparticles with anti-CD20 aptamers selectively suppress human CD20+ melanoma stem cells","volume":"39","author":"Zeng","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1155","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1634\/stemcells.2008-0601","article-title":"The stem cell-associated antigen CD133 (Prominin-1) is a molecular therapeutic target for metastatic melanoma","volume":"26","author":"Rappa","year":"2008","journal-title":"Stem Cells"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1160","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.canlet.2014.10.043","article-title":"CD133(+) melanoma subpopulation acquired resistance to caffeic acid phenethyl ester-induced apoptosis is attributed to the elevated expression of ABCB5: significance for melanoma treatment","volume":"357","author":"El-Khattouti","year":"2015","journal-title":"Cancer Lett."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1165","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.jconrel.2015.03.008","article-title":"Light-controlled endosomal escape of the novel CD133-targeting immunotoxin AC133-saporin by photochemical internalization - A minimally invasive cancer stem cell-targeting strategy","volume":"206","author":"Bostad","year":"2015","journal-title":"J. Control. Release"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1170","doi-asserted-by":"crossref","first-page":"51138","DOI":"10.18632\/oncotarget.9939","article-title":"Etoposide-Bevacizumab a new strategy against human melanoma cells expressing stem-like traits","volume":"7","author":"Calvani","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1175","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jphs.2018.02.003","article-title":"Morin inhibits proliferation and self-renewal of CD133(+) melanoma cells by upregulating miR-216a","volume":"136","author":"Hu","year":"2018","journal-title":"J. Pharmacol. Sci."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1180","doi-asserted-by":"crossref","first-page":"755","DOI":"10.7150\/thno.10804","article-title":"Coating solid lipid nanoparticles with hyaluronic acid enhances antitumor activity against melanoma stem-like cells","volume":"5","author":"Shen","year":"2015","journal-title":"Theranostics"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1185","first-page":"1456","article-title":"ALDH1 bio-activates nNifuroxazide to eradicate ALDH(high) melanoma-initiating cells, Cell Chem","volume":"25","author":"Sarvi","year":"2018","journal-title":"Biol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1190","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/j.jid.2016.06.610","article-title":"Down-regulation of SOX2 underlies the inhibitory effects of the triphenylmethane gentian violet on melanoma cell self-renewal and survival","volume":"136","author":"Pietrobono","year":"2016","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1195","doi-asserted-by":"crossref","first-page":"84128","DOI":"10.18632\/oncotarget.11554","article-title":"Lunasin is a novel therapeutic agent for targeting melanoma cancer stem cells","volume":"7","author":"Shidal","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1200","doi-asserted-by":"crossref","first-page":"729","DOI":"10.31083\/ph.2018.8715","article-title":"Retinoic acid increases the anticancer effect of paclitaxel by inducing differentiation of cancer stem cells in melanoma","volume":"73","author":"Wang","year":"2018","journal-title":"Pharmazie"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1205","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1038\/cdd.2014.140","article-title":"Targeting proapoptotic protein BAD inhibits survival and self-renewal of cancer stem cells","volume":"21","author":"Sastry","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1210","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0090783","article-title":"Natural compounds\u2019 activity against cancer stem-like or fast-cycling melanoma cells","volume":"9","author":"Sztiller-Sikorska","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1215","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1002\/mc.22242","article-title":"Honokiol inhibits melanoma stem cells by targeting notch signaling","volume":"54","author":"Kaushik","year":"2015","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1220","doi-asserted-by":"crossref","first-page":"46801","DOI":"10.18632\/oncotarget.8695","article-title":"Use of a MCL-1 inhibitor alone to de-bulk melanoma and in combination to kill melanoma initiating cells","volume":"8","author":"Mukherjee","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1225","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.ejmech.2018.06.046","article-title":"A novel Anti-Cancer Stem Cells compound optimized from the natural symplostatin 4 scaffold inhibits Wnt\/beta-catenin signaling pathway","volume":"156","author":"Liu","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1230","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/jid.2014.464","article-title":"Combining a BCL2 inhibitor with the retinoid derivative fenretinide targets melanoma cells including melanoma initiating cells","volume":"135","author":"Mukherjee","year":"2015","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1235","doi-asserted-by":"crossref","first-page":"84594","DOI":"10.18632\/oncotarget.13141","article-title":"Combining a GSI and BCL-2 inhibitor to overcome melanoma\u2019s resistance to current treatments","volume":"7","author":"Mukherjee","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/j.semcancer.2019.06.019_bib1240","doi-asserted-by":"crossref","first-page":"15464","DOI":"10.1038\/srep15464","article-title":"Overshoot during phenotypic switching of cancer cell populations","volume":"5","author":"Sellerio","year":"2015","journal-title":"Sci. Rep."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1245","first-page":"949","article-title":"The enhanced antitumour response of pimozide combined with the IDO inhibitor LMT in melanoma","volume":"53","author":"Jia","year":"2018","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1250","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1111\/1440-1681.13049","article-title":"Inhibition of cancer stem cells promoted by Pimozide","volume":"46","author":"Goncalves","year":"2018","journal-title":"Clin. Exp. Pharmacol. Physiol."},{"key":"10.1016\/j.semcancer.2019.06.019_bib1255","doi-asserted-by":"crossref","first-page":"4569","DOI":"10.18632\/oncotarget.3174","article-title":"Antibiotics that target mitochondria effectively eradicate cancer stem cells, across multiple tumor types: treating cancer like an infectious disease","volume":"6","author":"Lamb","year":"2015","journal-title":"Oncotarget"}],"container-title":["Seminars in Cancer Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1044579X19300021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T21:46:50Z","timestamp":1778795210000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1044579X19300021"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,12]]},"references-count":251,"alternative-id":["S1044579X19300021"],"URL":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.06.019","relation":{},"ISSN":["1044-579X"],"issn-type":[{"value":"1044-579X","type":"print"}],"subject":[],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications","name":"articletitle","label":"Article Title"},{"value":"Seminars in Cancer Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.semcancer.2019.06.019","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}